Skip to main content
. Author manuscript; available in PMC: 2016 Apr 28.
Published in final edited form as: Curr Metabolomics. 2013;1(3):227–240. doi: 10.2174/2213235X113019990005

Fig. (4).

Fig. (4)

Results of the MCCV (200 iterations) shown in ROC space for PLS-DA models based on 3 metabolites used to discriminate hepatocellular carcinoma and hepatitis C patients. Each blue diamond represents an iteration of the true model; each red square represents an iteration of the permutation model [Reproduced with permission from ref. 63].